Biohaven Ltd.
13.88USD
-0.8100 (-5.51%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BHVN.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | — | — | — | — | 93.3M | 60.3M |
| Q1 | — | — | — | — | — | — |
| Q2 | — | — | — | — | — | — |
| Q3 | — | — | — | — | 50.0M | — |
| Q4 | — | — | — | — | 50.0M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -12.75 | -5.73 | -9.28 | -6.86 | -1.30 | -1.74 |
| Q1 | -2.46 | -1.03 | -2.20 | -2.17 | -.880 | — |
| Q2 | -5.16 | -1.32 | -3.64 | -1.94 | -.910 | — |
| Q3 | -1.75 | -1.50 | -1.70 | -1.64 | .158 | — |
| Q4 | -4.49* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -2.03* |
| -2.05* |
| -1.35* |
| -.134 |
| — |
Debt level and coverage